One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Mediators of Racial Disparity in the Use of Prostate Magnetic Resonance Imaging Among Patients With Prostate Cancer
Michael S. Leapman, MD; Michaela Dinan, PhD; Saamir Pasha, MPH; et al.
doi : 10.1001/jamaoncol.2021.8116
May 2022, Vol 8, No. 5, Pages 669-788
Efficacy of HD201 vs Referent Trastuzumab in Patients With ERBB2-Positive Breast Cancer Treated in the Neoadjuvant SettingA Multicenter Phase 3 Randomized Clinical Trial
Xavier Pivot, MD, PhD; M. A. Georgievich, MD; Volodymyr Shamrai, MD; et al.
Effect of Induction Chemotherapy With Paclitaxel, Cisplatin, and Capecitabine vs Cisplatin and Fluorouracil on Failure-Free Survival for Patients With Stage IVA to IVB Nasopharyngeal CarcinomaA Multicenter Phase 3 Randomized Clinical Trial
Wang-Zhong Li, MD; Xing Lv, MD; Dan Hu, MS; et al.
Rates of Guideline-Concordant Surgery and Adjuvant Chemotherapy Among Patients With Early-Stage Lung Cancer in the US ALCHEMIST Study (Alliance A151216)
Kenneth L. Kehl, MD, MPH; David Zahrieh, PhD; Ping Yang, MD, PhD; et al.
Risk of Colorectal Cancer Associated With Lifetime Excess Weight
Xiangwei Li, MSc; Lina Jansen, PhD; Jenny Chang-Claude, PhD; et al.
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced AngiosarcomaA Randomized Clinical Trial
Robin L. Jones, MD; Vinod Ravi, MD; Andrew S. Brohl, MD; et al.
Association of Patient-Reported Outcomes With Subsequent Nonfatal Self-injury After a New Cancer Diagnosis
Julie Hallet, MD, MSc; Rinku Sutradhar, PhD; Elie Isenberg-Grzeda, MDCM; et al.
Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients
Michel Obeid, MD, PhD; Madeleine Suffiotti, PhD; Celine Pellaton, PhD; et al.
Evaluation of Antibody Response to SARS-CoV-2 mRNA-1273 Vaccination in Patients With Cancer in Florida
Anna R. Giuliano, PhD; Jeffrey E. Lancet, MD; Shari Pilon-Thomas, PhD; et al.
Differences in Thickness-Specific Incidence and Factors Associated With Cutaneous Melanoma in the US From 2010 to 2018
Michael L. Chen, BA; Isabella Joy de Vere Hunt, MD; Esther M. John, PhD, MSPH; et al.
Use of Early Intrathecal Therapy to Manage High-Grade Immune Effector Cell-Associated Neurotoxicity Syndrome
Joanna C. Zurko, MD; Bryon D. Johnson, PhD; Emilie Aschenbrenner, PharmD; et al.
Self-reported Transportation Barriers to Health Care Among US Cancer Survivors
Changchuan Jiang, MD, MPH; K. Robin Yabroff, PhD, MBA; Lei Deng, MD; et al.
Association of Changes in Medicaid Dental Benefits With Localized Diagnosis of Oral Cavity Cancer
Lulia A. Kana, MD, MS; Evan M. Graboyes, MD, MPH; Daniel Quan, MD; et al.
Diagnosis and Treatment of ERBB2-Positive Metastatic Colorectal CancerA Review
John H. Strickler, MD; Takayuki Yoshino, MD, PhD; Rondell P. Graham, MBBS; et al.
An Intramedullary Enigma
Nayan Lamba, MD; Danielle S. Bitterman, MD
Oncological Applications of Deep Learning Generative Adversarial Networks
Harrison Phillips; Shelly Soffer, MD; Eyal Klang, MD
Biased Evaluation in Cancer Drug Trials—How Use of Progression-Free Survival as the Primary End Point Can Mislead
Ian F. Tannock, MD, PhD; Gregory R. Pond, PhD; Christopher M. Booth, MD
Palliative Care Is the Umbrella, Not the Rain—A Metaphor to Guide Conversations in Advanced Cancer
Camilla Zimmermann, MD, PhD; Jean Mathews, MD
JAMA Oncology—The Year in Review, 2021
Mary L. (Nora) Disis, MD
Racist Factors Underlying Prostate Cancer Disparities
Michael Poulson, MD, MPH
Induction Chemotherapy for Advanced Nasopharyngeal Carcinoma—Is This the New Standard of Care?
Maurice Willis, MD
Translating Clinical Trial Evidence to Routine Practice—How Do We Overcome the Barriers?
Monica Tang, MBBS, MMed; Chee Khoon Lee, MBBS, MMedSci, MBiostat, PhD
Exposure Histories and Cancer Risk—What Can We Learn?
Patrick T. Bradshaw, PhD
Financial Toxicity of Cancer Treatment
S. M. Qasim Hussaini, MD, MS; Arjun Gupta, MD; Stacie B. Dusetzina, PhD
A Radiation Oncologist’s Experience With Medical Aid in Dying
Santosh V. Yajnik, MD
Internal Mammary Nodal Irradiation Debate for Node-Positive Breast Cancer—Has the Needle Moved?
Jose G. Bazan, MD, MS; Julia R. White, MD
Internal Mammary Nodal Irradiation Debate for Node-Positive Breast Cancer—Has the Needle Moved?—Reply
Hwa Kyung Byun, MD, PhD; Yong Bae Kim, MD, PhD; Chang-Ok Suh, MD, PhD
Do We Have Enough Evidence to Propose a Preferred Total Neoadjuvant Therapy Sequence for Patients With Locally Advanced Rectal Cancer?
Robert Siegel, MD
Do We Have Enough Evidence to Propose a Preferred Total Neoadjuvant Therapy Sequence for Patients With Locally Advanced Rectal Cancer?—Reply
Emmanouil Fokas, MD, DPhil; Claus Rödel, MD
Cabozantinib for Treatment of Brain Metastases in Patients With Renal Cell Carcinoma
Binghao Zhao, MD, PhD; Wenbin Ma, MD
Cabozantinib for Treatment of Brain Metastases in Patients With Renal Cell Carcinoma
Alessandro Rizzo, MD; Veronica Mollica, MD; Francesco Massari, MD
